Frazier Financial Advisors »

Mersana Therapeutics shares owned by Frazier Financial Advisors

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Frazier Financial Advisors from 13F filings

Historical chart of Frazier Financial Advisors investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Frazier Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Frazier Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $10 5 2.00
2024-06-30 $11 5 2.20
2024-03-31 $23 5 4.60

More positions owned by Frazier Financial Advisors

Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Wisdomtree Tr Currncy Int Eq (DDWM)
Wisdomtree Tr Us Midcap Divid (DON)
Accenture Plc Ireland Shs Class A (ACN)
Vanguard Index Fds Small Cp Etf (VB)
Wisdomtree Tr Us Smallcap Divd (DES)
Abbvie (ABBV)
Apple (AAPL)
Abbott Laboratories (ABT)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
JPMorgan Chase & Co. (JPM)
Bath &#38 Body Works In (BBWI)

View all positions for Frazier Financial Advisors

Top funds holding Mersana Therapeutics

EcoR1 Capital
Nextech Invest
VR Adviser
Bain Capital Life Sciences Investors
BlackRock
BlackRock
Vanguard Group
Citadel Advisors
Rock Springs Capital Management
State Street Corporation
Cormorant Asset Management
Silverarc Capital Management
Geode Capital Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Mersana Therapeutics